NIOX Group (LON:NIOX) Trading 0.9% Higher - Still a Buy?

NIOX Group Plc (LON:NIOX - Get Free Report)'s share price traded up 0.9% on Tuesday . The stock traded as high as GBX 68 ($0.90) and last traded at GBX 67 ($0.89). 443,078 shares changed hands during mid-day trading, a decline of 60% from the average session volume of 1,104,803 shares. The stock had previously closed at GBX 66.40 ($0.88).

Analyst Ratings Changes

A number of brokerages have issued reports on NIOX. Berenberg Bank reaffirmed a "buy" rating and set a GBX 90 ($1.20) target price on shares of NIOX Group in a research report on Tuesday, April 15th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a GBX 90 ($1.20) price target on shares of NIOX Group in a report on Tuesday, April 15th.

NIOX Group Stock Performance

The stock has a market cap of £27.43 billion, a price-to-earnings ratio of 2,756.47 and a beta of 0.92. The firm has a fifty day simple moving average of GBX 65.80 and a 200 day simple moving average of GBX 63.51. The company has a current ratio of 6.31, a quick ratio of 1.94 and a debt-to-equity ratio of 1.10.

NIOX Group (LON:NIOX - Get Free Report) last posted its earnings results on Tuesday, April 1st. The company reported GBX 2.27 ($0.03) earnings per share for the quarter. NIOX Group had a net margin of 28.21% and a return on equity of 13.29%. As a group, sell-side analysts expect that NIOX Group Plc will post 1.1658256 earnings per share for the current year.

Insider Transactions at NIOX Group

In related news, insider Jonathan Emms purchased 127,454 shares of NIOX Group stock in a transaction that occurred on Tuesday, April 1st. The stock was purchased at an average cost of GBX 8 ($0.11) per share, with a total value of £10,196.32 ($13,564.35). 46.72% of the stock is currently owned by corporate insiders.

About NIOX Group

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo level in patients.